nach oben

Inflammation Research

Erschienen in:

01.03.2012 | Original Research Paper

The NLRP3 inflammasome is active but not essential in endotoxin-induced uveitis

Erschienen in: Inflammation Research | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Objective

The inflammasome complex involving caspase-1 and nucleotide-binding domain, leucine-rich repeat containing protein (NLRP)3, also known as NALP3 or cryopyrin is important for host responses to microbial pathogens and several autoinflammatory diseases. We investigated the extent to which NLRP3 and caspase-1 control ocular interleukin (IL)-1β production and severity of uveitis (intraocular inflammatory disease) in an established, acute inflammatory uveitis model, endotoxin-induced uveitis (EIU).

Methods

Expression of NLRP3, its adaptor molecule ASC, also known as PYCARD (PYD and CARD domain containing), and caspase-1 were examined by immunoblotting. IL-1β production was measured by enzyme-linked immunosorbent assay (ELISA). Using knockout mice, roles for caspase-1 and NLRP3 were examined in uveitis induced by intraocular injection of Escherichia coli lipopolysaccharide (LPS).

Results

NLRP3, ASC, and caspase-1 proteins are constitutively expressed in eye tissue. During EIU, IL-1β protein production increases; this requires the presence of both caspase-1 and NLRP3. However, severity of EIU is not altered by deficiency in either caspase-1 or NLRP3, as assessed by both intravital microscopy and histology.

Conclusions

These data identify the importance of the NLRP3 inflammasome for IL-1β production in the eye, yet indicate that its participation in EIU is nonessential.

Martinon F, Mayor A, Tschopp J. The Inflammasomes: Guardians of the Body. Annu Rev Immunol. 2009;27:229–65.PubMedCrossRef

Brodsky IE, Monack D. NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens. Semin Immunol. 2009;21:199–207.PubMedCrossRef

Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol. 2011;29:707–35.PubMedCrossRef

Goldbach-Mansky R, Kastner DL. Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses. J Allergy Clin Immunol. 2009;124:1141–9.PubMedCrossRef

Chitkara P, Stojanov S, Kastner DL. The hereditary autoinflammatory syndromes. Pediatr Infect Dis. 2007;26:353–4.CrossRef

Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011;117:3720–32.PubMedCrossRef

McGarry F, Neilly J, Anderson N, Sturrock R, Field M. A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology. 2001;40:1359–64.PubMedCrossRef

Gabay C, Lamacchia C, Palmer G. IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol. 2010;6:232–41.PubMedCrossRef

Djouadi K, Nedelec B, Tamouza R, Genin E, Ramasawmy R, Charron D, et al. Interleukin 1 gene cluster polymorphisms in multiplex families with spondylarthropathies. Cytokine. 2001;13:98–103.PubMedCrossRef

10.

Maksymowych WP, Reeve JP, Reveille JD, Akey JM, Buenviaje H, O’Brien L, et al. High-throughput single-nucleotide polymorphism analysis of the IL1RN locus in patients with ankylosing spondylitis by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. Arthritis Rheum. 2003;48:2011–8.PubMedCrossRef

11.

Hutyrova B, Pantelidis P, Drabek J, Zurkova M, Kolek V, Lenhart K, et al. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2002;165:148–51.PubMed

12.

Coskun M, Bacanli A, Sallakci N, Alpsoy E, Yavuzer U, Yegin O. Specific interleukin-1 gene polymorphisms in Turkish patients with Behçet’s disease. Exp Dermatol. 2005;14:124–9.PubMedCrossRef

13.

Karasneh J, Hajeer AH, Barrett J, Ollier WE, Thornhill M, Gul A. Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet’s disease. Rheumatology. 2003;42:860–4.PubMedCrossRef

14.

Gonzalez-Benitez JF, Juarez-Verdayes MA, Rodriguez-Martinez S, Cancino-Diaz ME, Garcia-Vasquez F, Cancino-Diaz JC. The NALP3/Cryopyrin-inflammasome complex is expressed in LPS-induced ocular inflammation. Mediators Inflamm 2008;2008:7.

15.

Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR. Endotoxin-induced uveitis in rats as a model for human disease. Nature. 1980;286:611–3.PubMedCrossRef

16.

Becker MD, Nobiling R, Planck SR, Rosenbaum JT. Digital video-imaging of leukocyte migration in the iris: intravital microscopy in a physiological model during the onset of endotoxin-induced uveitis. J Immunol Methods. 2000;240:23–37.PubMedCrossRef

17.

Rosenzweig HL, Martin TM, Jann MM, Planck SR, Davey MP, Kobayashi K, et al. NOD2, the gene responsible for familial granulomatous uveitis, is essential in a mouse model of muramyl dipeptide-induced uveitis. Invest Ophthalmol Vis Sci. 2008;49:1518–24.PubMedCrossRef

18.

Rosenzweig H, Galster K, Planck S, Rosenbaum J. NOD1 expression in the eye and functional contribution to IL-1{beta} dependent ocular inflammation in mice. Invest Ophthalmol Vis Sci. 2009;50:1746–53.PubMedCrossRef

19.

Yu HB, Finlay BB. The caspase-1 inflammasome: a pilot of innate immune responses. Cell Host Microbe. 2008;11:198–208.CrossRef

20.

Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kosturan MJ, et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature. 1992;356:768–74.PubMedCrossRef

21.

Willingham SB, Allen IC, Bergstralh DT, Brickey WJ, Huang MT, Taxman DJ, et al. NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways. J Immunol. 2009;183:2008–15.PubMedCrossRef

22.

Reimer T, Shaw MH, Franchi L, Coban C, Ishii KJ, Akira S, et al. Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome. Eur J Immunol. 2010;40:764–9.PubMedCrossRef

23.

Becker MD, O’Rourke LM, Blackman WS, Planck SR, Rosenbaum JT. Reduced leukocyte migration, but normal rolling and arrest, in interleukin-8 receptor homologue knockout mice. Invest Ophthalmol Vis Sci. 2000;41:1812–7.PubMed

24.

Tuaillon N, Shen DF, Berger RB, Lu B, Rollins BJ, Chan CC. MCP-1 expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 2002;43:1493–8.PubMed

25.

Whitcup SM, DeBarge R, Caspi RR, Harning R, Nussenblatt RB, Chan C–C. Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) inhibit experimental autoimmune uveitis. Clin Immunol Immunopathol. 1993;67:143–50.PubMedCrossRef

26.

Rosenbaum JT, Han YB, Park JM, Kennedy M, Planck SR. TNFα is not a major mediator of endotoxin-induced uveitis: studies in cytokine receptor deficient mice. J Rheumatol. 1998;25:2408–516.PubMed

27.

Rosenzweig HL, Martin TM, Planck SR, Galster K, Jann MM, Davey MP, et al. Activation of NOD2 in vivo induces IL-1 beta production in the eye via caspase-1 but results in ocular inflammation independently of IL-1 signaling. J Leukoc Biol. 2008;84:529–36.PubMedCrossRef

28.

Arostegui J, Arnal C, Merino R, Modesto C, Antonia Caballo J, Moreno P, et al. NON2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum. 2007;56:3805–13.PubMedCrossRef

29.

Martin TM, Zhang Z, Kurz P, Rose CD, Chen H, Lu H, et al. The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity. Arthritis Rheum. 2009;60:611–8.PubMedCrossRef

30.

Brito BE, O’Rourke L, Pan Y, Anglin J, Planck SR, Rosenbaum JT. IL-1 and TNF receptor deficient mice show decreased inflammation in an immune complex model of uveitis. Invest Ophthalmol Vis Sci. 1999;40:2583–9.PubMed

31.

Su SB, Silver PB, Grajewski RS, Agarwal RK, Tang J, Chan CC, et al. Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. J Immunol. 2005;175:6303–10.PubMed

32.

Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS-S, et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1á converting enzyme. Science. 1995;267:2000–3.PubMedCrossRef

33.

Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature. 1997;386:619–23.PubMedCrossRef

34.

Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell. 1995;80:401–11.PubMedCrossRef

35.

Shen DF, Buggage RR, Engl HC, Chan CC. Cytokine gene expression in different strains of mice with endotoxin-induced uveitis (EIU). Ocul Immunol Inflamm. 2000;8:221–5.PubMedCrossRef

36.

Imai H, Ohta K, Yoshida A, Suzuki S, Hashizume K, Usami S, et al. {micro}-Crystallin, new candidate protein in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 2010;51:3554–9.PubMedCrossRef

37.

Netea MG, Nold-Petry CA, Nold MF, Joosten LA, Optiz B, van der Meer JH, et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood. 2009;113:2324–35.PubMedCrossRef

38.

Piccini A, Carta S, Tassi S, Lasiglie D, Fossati G, Rubartelli A. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1β and IL-18 secretion in an autocrine way. Proc Natl Acad Sci USA. 2008;105:8067–72.PubMedCrossRef

39.

Teoh SC, Sharma S, Hogan A, Lee R, Ramanan AV, Dick AD. Tailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndrome. Br J Ophthalmol. 2007;91:263–4.PubMedCrossRef

40.

Deal watch: XOMA, Servier to develop anti-IL-1β antibody for inflammatory diseases. Nat Rev Drug Discov 2011;10:166.

Titel: The NLRP3 inflammasome is active but not essential in endotoxin-induced uveitis
Publikationsdatum: 01.03.2012
Erschienen in: Inflammation Research / Ausgabe 3/2012
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI: https://doi.org/10.1007/s00011-011-0404-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypertonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The NLRP3 inflammasome is active but not essential in endotoxin-induced uveitis

Abstract

Objective

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Metformin rückt in den Hintergrund

Update Innere Medizin

Springer Medizin

Abstract

Objective

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis

A20 and ABIN-3 possibly promote regression of trehalose 6,6′-dimycolate (TDM)-induced granuloma by interacting with an NF-kappa B signaling protein, TAK-1

TLR4 polymorphisms and disease susceptibility

Annexin A1 protein attenuates cyclosporine-induced renal hemodynamics changes and macrophage infiltration in rats

Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits

Anti-inflammatory effects of kaempferol-3-O-sophoroside in human endothelial cells

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Metformin rückt in den Hintergrund

Update Innere Medizin